Stem Cells http://www.peprotech.com/
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online August 18, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2004-0366v1
23/9/1304    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sasaki, E.
Right arrow Articles by Tani, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sasaki, E.
Right arrow Articles by Tani, K.
Submitted on December 22, 2004
Accepted on May 5, 2005

Original Article

Establishment of Novel Embryonic Stem Cell Lines Derived from the Common Marmoset (Callithrix jacchus)

Erika Sasaki 1, Kisaburo Hanazawa 2, Ryo Kurita 3, Akira Akatsuka 4, Takahito Yoshizaki 5, Hajime Ishii 1, Yoshikuni Tanioka 1, Yasuyuki Ohnishi 6, Hiroshi Suemizu 6, Ayako Sugawara 7, Norikazu Tamaoki 6, Kiyoko Izawa 8, Yukoh Nakazaki 3, Hiromi Hamada 9, Hirofumi Suemori 10, Shigetaka Asano 8, Norio Nakatsuji 11, Hideyuki Okano 5, Kenzaburo Tani 12*

1 Division of Laboratory Animal Science, Central Institute for Experimental Animals, Japan
2 Department of Urology, Urayasu Hospital, Juntendo University, Japan
3 Department of Molecular Genetics, Division of Molecular and Clinical Genetics, Medical Institute of Bioregulation, Kyushu University, Japan
4 Tokai University School of Medicine, Japan
5 Department of Physiology, Keio University School of Medicine, Japan
6 Research Project Center, Central Institute for Experimental Animals, Japan
7 Department of Genetics, Central Institute for Experimental Animals, Japan
8 Division of Molecular Therapy, Institute of Medical Science, University of Tokyo
9 Institute of Obstetrics and Gynecology in Clinical Medicine, University of Tsukuba
10 Laboratory of Embryonic Stem Cell Research, Stem Cell Research Center, Institute for Frontier Medical Sciences, Kyoto University
11 Department of Development and Differentiation, Institute for Frontier Medical Sciences, Kyoto University
12 Division of Molecular and Clinical Genetics, Medical Institute of Bioregulation, Kyushu University, Japan

* To whom correspondence should be addressed. E-mail: taniken{at}bioreg.kyushu-u.ac.jp.


   Abstract

The successful establishment of human embryonic stem (ES) cell lines has inaugurated a new era in regenerative medicine by facilitating the transplantation of differentiated embryonic stem cells to specific organs. However, problems with the safety and efficacy of human embryonic stem cell therapy in vivo remain to be resolved. Pre-clinical studies using animal model systems, including non-human primates, are essential to evaluate the safety and efficacy of human embryonic stem cell therapies. Previously, we demonstrated that common marmosets are suitable laboratory animal models for pre-clinical studies of hematopoietic stem cell therapies. As this animal model is also applicable to pre-clinical trials of ES cell therapies, we have established novel common marmoset embryonic stem (CMES) cell lines. To obtain marmoset embryos, we developed a new embryo collection system, in which blastocysts can be obtained every three weeks from each marmoset pair. The inner cell mass (ICM) was isolated by immunosurgery and plated on a mouse embryonic feeder (MEF) layer. Some of the CMES lines were cultured continuously for more than one year. These CMES cell lines showed alkaline phosphatase activity, and expressed stage-specific embryonic antigen (SSEA)-3, SSEA-4, TRA-1-60, and TRA-1-81. On the other hand, SSEA-1 was not detected. Furthermore, our novel CMES cells are pluripotent, as evidenced by in vivo teratoma formation in immunodeficient mice and in vitro differentiation experiments. Our established CMES cell lines and the common marmoset provide an excellent experimental model system for understanding differentiation mechanisms, as well for the development of regenerative therapies using human ES cells.




This article has been cited by other articles:


Home page
IOVSHome page
P. Charalambous, L. A. Hurst, and S. Thanos
Engrafted Chicken Neural Tube-Derived Stem Cells Support the Innate Propensity for Axonal Regeneration within the Rat Optic Nerve
Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3513 - 3524.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
T. Muller, K. Eildermann, R. Dhir, S. Schlatt, and R. Behr
Glycan stem-cell markers are specifically expressed by spermatogonia in the adult non-human primate testis
Hum. Reprod., July 10, 2008; (2008) den253v1.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
B. Hayes, S. R. Fagerlie, A. Ramakrishnan, S. Baran, M. Harkey, L. Graf, M. Bar, A. Bendoraite, M. Tewari, and B. Torok-Storb
Derivation, Characterization, and In Vitro Differentiation of Canine Embryonic Stem Cells
Stem Cells, February 1, 2008; 26(2): 465 - 473.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. S. Navara, J. D. Mich-Basso, C. J. Redinger, A. Ben-Yehudah, E. Jacoby, E. Kovkarova-Naumovski, M. Sukhwani, K. Orwig, N. Kaminski, C. A. Castro, et al.
Pedigreed Primate Embryonic Stem Cells Express Homogeneous Familial Gene Profiles
Stem Cells, November 1, 2007; 25(11): 2695 - 2704.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Senju, H. Suemori, H. Zembutsu, Y. Uemura, S. Hirata, D. Fukuma, H. Matsuyoshi, M. Shimomura, M. Haruta, S. Fukushima, et al.
Genetically Manipulated Human Embryonic Stem Cell-Derived Dendritic Cells with Immune Regulatory Function
Stem Cells, November 1, 2007; 25(11): 2720 - 2729.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
A. Silvestri and H. M Fraser
Oestrogen and progesterone receptors in the marmoset endometrium: changes during the ovulatory cycle, early pregnancy and after inhibition of vascular endothelial growth factor, GnRH or ovariectomy
Reproduction, August 1, 2007; 134(2): 341 - 353.
[Abstract] [Full Text] [PDF]


Home page
J. Med. EthicsHome page
H-W Denker
Potentiality of embryonic stem cells: an ethical problem even with alternative stem cell sources.
J. Med. Ethics, November 1, 2006; 32(11): 665 - 671.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
S. Mitalipov, H.-C. Kuo, J. Byrne, L. Clepper, L. Meisner, J. Johnson, R. Zeier, and D. Wolf
Isolation and Characterization of Novel Rhesus Monkey Embryonic Stem Cell Lines
Stem Cells, October 1, 2006; 24(10): 2177 - 2186.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
R. Kurita, E. Sasaki, T. Yokoo, T. Hiroyama, K. Takasugi, H. Imoto, K. Izawa, Y. Dong, T. Hashiguchi, Y. Soda, et al.
Tal1/Scl Gene Transduction Using a Lentiviral Vector Stimulates Highly Efficient Hematopoietic Cell Differentiation from Common Marmoset (Callithrix jacchus) Embryonic Stem Cells
Stem Cells, September 1, 2006; 24(9): 2014 - 2022.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
STEM CELLS THE ONCOLOGIST CME ALPHAMED PRESS JOURNALS

Copyright © 2005 by AlphaMed Press.